세계 신경 재생 요법 시장 : 신경 재생 요법 유형별, 적응증별, 투여 방법별, 연령층별, 최종 사용자별, 지역별

Global neuroregeneration therapy market size is estimated to be valued at US$ 11.67 Bn in 2023, and is expected to reach US$ 26.61 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2023 to 2030.

Figure 1. Global Neuroregeneration Therapy Market Share (%),By Region, 2023

Neuroregeneration refers to the process of regenerating or repairing nervous tissue, including neurons, axons, synapses, and glial cells. This process is crucial for replacing damaged tissues due to injury and ensuring long-term functional recovery. It involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a significant role in combating memory disorders and abnormalities related to aging. By pharmacologically stimulating neuroregeneration, it's possible to rescue cognitive functions, thereby improving memory and other cognitive abilities. In essence, neuroregeneration is a critical biological process with significant implications for treating various neurological conditions and improving brain health.

Market Dynamics:

The global neuroregeneration therapy market is expected to witness significant growth in the coming years, driven by several key factors. Firstly, the increasing prevalence of neurological disorders, including both central and peripheral nervous system disorders, is creating a high demand for effective and safe treatments. These disorders can have a debilitating impact on patients' lives, making the need for neuroregenerative therapies crucial. Secondly, the world's aging population is growing rapidly. Older individuals are more susceptible to neurological conditions, which further increases the demand for these therapies. As people seek treatments that can improve their quality of life, the market for neuroregeneration therapies is expected to expand. Lastly, there is a surge in research and development activities in the field of neuroregeneration. Scientists and researchers are continually exploring new treatment methods and making breakthroughs in understanding how to stimulate the repair and regrowth of nervous tissue. This ongoing innovation is expected to introduce new therapies to the market, driving further growth. In summary, the combination of a high disease burden, an aging population, and active research and development are set to propel the global neuroregeneration therapy market forward.

For instance, on February 6, 2023, Biogen Inc., a biotechnology company, and Sage Therapeutics, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) had accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational drug being evaluated as a 14-day, rapid-acting, once-daily, oral treatment in adults with MDD and PPD.

Key features of the study:

• This report provides in-depth analysis of the global neuroregeneration therapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global neuroregeneration therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Biogen Inc., AstraZeneca PLC, Pfizer Inc., Novartis International AG, Merck & Co., Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Ceregene Inc., Stemedica Cell Technologies, Inc., Lineage Cell Therapeutics, Inc., StemCells Inc., Ever Supreme Bio Technology Co., Ltd. and AbbVie
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global neuroregeneration therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroregeneration therapy market

Detailed Segmentation:

• By Type of Neuroregeneration Therapy:
  • Stem Cell Therapy
  • Gene Therapy
  • Pharmacological Therapy
  • Neurostimulation Therapy
  • Others
• By Indication:
  • Spinal Cord Injury
  • Stroke
  • Traumatic Brain Injury
  • Parkinson's Disease
  • Alzheimer's Disease
  • Multiple Sclerosis
  • Peripheral Nerve Injury
  • Others
• By Mode of Administration:
  • Oral
  • Injectable
  • Implantable
  • Others
• By Age Group:
  • Pediatric
  • Adult
  • Geriatric
• By End User:
  • Hospitals
  • Specialty Clinics
  • Research Institutes
  • Rehabilitation Centers
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Biogen Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Novartis International AG
  • Merck & Co., Inc.
  • Sanofi S.A.
  • F.Hoffmann-La Roche Ltd.
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Ceregene Inc.
  • Lineage Cell Therapeutics, Inc.
  • Stemedica Cell Technologies, Inc.
  • StemCells Inc.
  • Ever Supreme Bio Technology Co., Ltd.
  • AbbVie

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type of Neuroregeneration Therapy
  • Market Snippet, By Indication
  • Market Snippet, By Mode of Administration
  • Market Snippet, By Age Group
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing burden of neurological disorders
  • High cost and dearth of skilled professionals
  • High demand for safe and effective therapeutics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Neuroregeneration Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Stem Cell Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Gene Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Pharmacological Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Neurostimulation Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Neuroregeneration Therapy Market, By Indication, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Spinal Cord Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Stroke
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Traumatic Brain Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Bn)
• Parkinson's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Alzheimer's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Multiple Sclerosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030 ,(US$ Bn)
• Peripheral Nerve Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Neuroregeneration Therapy Market, By Mode of Administration, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Implantable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Other
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Neuroregeneration Therapy Market, By Age Group, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Neuroregeneration Therapy Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Rehabilitation Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

10. Global Neuroregeneration Therapy Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
• South Africa
• North Africa
• Central Africa

11. Competitive Landscape

• Biogen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca PLC
• Pfizer Inc.
• Novartis International AG
• Merck & Co., Inc.
• Sanofi S.A.
• F. Hoffmann-La Roche Ltd.
• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Ceregene Inc.
• Lineage Cell Therapeutics, Inc.
• Stemedica Cell Technologies, Inc.
• StemCells Inc.
• Ever Supreme Bio Technology Co., Ltd.
• AbbVie
• Analyst Views

12. Section

• Research Methodology
• About us